the effects of liver disease on caffeine plasma clearance ( cl ) and on exhalation of 14co2 following i.v . injection of 2 mu ci of [ 3-methyl-14c ] caffeine together with 125 mg of the unlabeled compound were measured in 15 patients with cirrhosis , 11 subjects with miscellaneous liver disease , and 10 normal volunteers .
C0023890
cirrhosis
C0023895
liver disease